Tectonic Therapeutic Inc.

17.89
0.87 (5.11%)
At close: Apr 21, 2025, 3:59 PM
18.23
1.90%
Pre-market: Apr 22, 2025, 04:25 AM EDT
5.11%
Bid 17
Market Cap 333.88M
Revenue (ttm) n/a
Net Income (ttm) -49.57M
EPS (ttm) -6.83
PE Ratio (ttm) -2.62
Forward PE -3.54
Analyst Buy
Ask 18.23
Volume 119,055
Avg. Volume (20D) 374,306
Open 17.56
Previous Close 17.02
Day's Range 16.86 - 18.25
52-Week Range 1.40 - 61.07
Beta 1.38

About TECX

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 51
Stock Exchange NASDAQ
Ticker Symbol TECX
Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for TECX stock is "Buy." The 12-month stock price forecast is $67, which is an increase of 274.51% from the latest price.

Stock Forecasts
2 months ago
+113.22%
Tectonic Therapeutic shares are trading higher aft... Unlock content with Pro Subscription